Author: Staff

Cardinal Spine filed a form D announcing $1.25 million in equity financing, according to an OctaFinance report.

A Medscape survey found 74 percent of healthcare professionals are very concerned about opioid abuse.

Anika Therapeutics, a global orthopedic medicines company, had its first patient enroll in its HYALOFAST FastTRACK Phase III clinical study.

Nashville, Tenn.-based Vanderbilt University researchers discovered fibrin is not crucial for bone fracture healing, contrary to popular belief. Rather, fibrin's breakdown and clearance are important to the healing process, according to MD News.

Healthcare technology company, iTENS, released the world's first FDA-cleared, wireless therapy device.

San Antonio-based Premier Pain Consultants is offering radiofrequency ablation for patients with chronic knee pain.

Terrence A. Sedgewick, MD, specializes in arthroscopic and non-invasive treatment of sports medicine injuries.

Amedica has signed an international private label supply agreement with BoTEC Medical.

A recent study found that more than 90 percent of patients suffering from chronic pain continue to receive prescription painkillers following an overdose, according to Neurology Advisor.

In a study published in The Journal of Arthroplasty, researchers found risk-adjusted prolonged length of stay was an inadequate measure of surgical safety among patients who underwent total hip or knee arthroplasty.